Back to search

Article

Determination of Critical Concentration for Drug Susceptibility Testing of Mycobacterium tuberculosis against Para-Aminosalicylic Acid with clinical isolates with thyA, folC and dfrA mutations

2022-08-03

Abstract excerpt

<h4>Background: </h4> & Objectives Accurate determination of antimicrobial resistance profiles is of great importance to formulate optimal regimens against multidrug-resistant tuberculosis (MDR-TB). Although para-aminosalicylic acid (PAS) has been widely used clinically, the reliable testing methods for PAS susceptibility were not established. Herein, we aimed to establish critical test concentration for PAS on th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c0824fc7-69b1-5645-9657-d973791ac256
DOI
10.21203/rs.3.rs-1903383/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Determination of Critical Concentration for Drug Susceptibility Testing of Mycobacterium tuberculosis against Para-Aminosalicylic Acid with clinical isolates with thyA, folC and dfrA mutationsDOI 10.21203/rs.3.rs-1903383/v1
Determination of critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against para-aminosalicylic acid with clinical isolates with thyA, folC and dfrA mutations.Semantic proximity
Minimum inhibitory concentration of cycloserine against Mycobacterium tuberculosis using the MGIT 960 system and a proposed critical concentration.Semantic proximity
Molecular genetics of para-aminosalicylic acid resistance in clinical isolates and spontaneous mutants of Mycobacterium tuberculosis.Semantic proximity
Genetic determinants involved in p-aminosalicylic acid resistance in clinical isolates from tuberculosis patients in northern China from 2006 to 2012.Semantic proximity
Evidence for Expanding the Role of Streptomycin in the Management of Drug-Resistant Mycobacterium tuberculosis.Semantic proximity
Performance Evaluation of the BACTEC MGIT 960 System for Rifampin Drug-Susceptibility Testing of Mycobacterium tuberculosis Using the Current WHO Critical Concentration.Semantic proximity
Linking minimum inhibitory concentrations to whole genome sequence-predicted drug resistance in Mycobacterium tuberculosis strains from Romania.Semantic proximity
Drug susceptibility of the Mycobacterium genus: in vitro tests and clinical implications.Semantic proximity
Discordance in Genotypic and Phenotypic anti-tuberculosis drug susceptibility results: time to reconsider critical concentrationSemantic proximity
Re-evaluation of critical concentrations of antituberculosis fluoroquinolones in the Mycobacteria Growth Indicator Tube 960 system.Semantic proximity
Current drug susceptibility testing in the Löwenstein-Jensen medium leads to underestimating of prothionamide resistance in multi-drug resistant Mycobacterium tuberculosis.Semantic proximity
The ins and outs of Mycobacterium tuberculosis drug susceptibility testing.Semantic proximity
Select a neighboring publication to make it the new centre.